Skip to content

Gross Profit at other companies

Abbott logo
AbbottABT
$6.27B+6.5%
Boston Scientific logo
Boston ScientificBSX
$3.61B+12.6%
IAR
Integra LifeSciencesIART
$216.98M+11.6%
Medtronic logo
MedtronicMDT
$6.41B+10.9%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$18.05M+4.1%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$538.61M+69.2%
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Calculated from ClearPoint Neuro’s reported figures.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's gross profit?
ClearPoint Neuro (CLPT) reported gross profit of $7.76M in Q1 2026.
How has ClearPoint Neuro's gross profit changed year-over-year?
ClearPoint Neuro's gross profit increased by 51.1% year-over-year, from $5.13M to $7.76M.
What is the long-term trend for ClearPoint Neuro's gross profit?
Over 4 years (2021 to 2025), ClearPoint Neuro's gross profit has grown at a 19.5% compound annual growth rate (CAGR), from $11.11M to $22.69M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.